A Porcine Model of Acute Autologous Pulmonary Embolism.
Simone Juel DragsbaekJacob Valentin HansenVictor Tang MeritMads Dam LyhneMathilde Emilie KirkAnders Dahl KramerMette Wørmer PoulsenChristian Schmidt MortensenJens Erik Nielsen-KudskAsger AndersenJacob Gammelgaard SchultzPublished in: Journal of visualized experiments : JoVE (2024)
Acute pulmonary embolism (PE) is a potentially life-threatening condition that causes abrupt obstruction of the pulmonary arteries, leading to acute right heart failure. Novel diagnostic methods and catheter-directed therapies are being developed rapidly, and there is an obvious need for a realistic PE animal model that can be used for pathophysiological evaluation and preclinical testing. This protocol introduces a porcine model employing large autologous pulmonary emboli. Instrumentations are performed with minimally invasive techniques, creating a close-chest model that enables the investigation of various treatment options with high reproducibility. Three hours after drawing blood to create autologous emboli ex vivo, the induction of PE caused an immediate increase in the mean pulmonary arterial pressure (17 ± 3 mmHg to 33 ± 6 mmHg, p < 0.0001) and heart rate (50 ± 9 beats·min -1 to 63 ± 6 beats·min -1 , p < 0.0003) accompanied by a decreased cardiac output (5.0 ± 0.8 L/min to 4.5 ± 0.9 L/min, p < 0.037) compared to baseline. The CT pulmonary angiography revealed multiple emboli, and the pulmonary obstruction percentage was increased compared to baseline (0% [0-0] to 57.1% [38.8-63.3], p < 0.0001). In the acute phase, the phenotype is comparable to intermediate-risk PE. The model represents a realistic and well-characterized phenotype of intermediate-risk PE and creates an opportunity to test novel diagnostic methods, interventional and pharmaceutical treatments, and hands-on training for healthcare workers in interventional procedures.
Keyphrases
- pulmonary embolism
- pulmonary hypertension
- heart rate
- liver failure
- heart failure
- inferior vena cava
- minimally invasive
- cell therapy
- respiratory failure
- blood pressure
- bone marrow
- randomized controlled trial
- drug induced
- left ventricular
- optical coherence tomography
- heart rate variability
- aortic dissection
- magnetic resonance imaging
- mesenchymal stem cells
- single cell
- magnetic resonance
- extracorporeal membrane oxygenation
- mechanical ventilation
- dual energy
- cardiac resynchronization therapy